MAGOHB and glioblastoma: Therefore, considering the impact of MAGOH and MAGOHB on cancer phenotypes and the dissimilar sensitivity to their knockdown between GBM and differentiated neuronal cells, targeting EJC members such as MAGOH and MAGOHB may be an alternative therapeutic strategy to treat GBM.